SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-143107
Filing Date
2017-04-27
Accepted
2017-04-27 16:31:03
Documents
3
Period of Report
2017-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d381477d8k.htm 8-K 14429
2 EX-99.1 d381477dex991.htm EX-99.1 61145
3 GRAPHIC g381477g98l83.gif GRAPHIC 3775
  Complete submission text file 0001193125-17-143107.txt   82340
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 17789542
SIC: 2834 Pharmaceutical Preparations